Clearance follows US clinical trials that show Tel Aviv-based Sight Diagnostics' product can do complete blood count in minutes, with lab-like accuracy, using pinprick of blood
Israeli firm plans to start selling the pill in the US in first quarter 2020, targeting more than 2 million patients treated for H. pylori infection annually; shares surge
If the Talicia drug to combat H. pylori bacterial infection gets approved, commercial launch is planned for the fourth quarter of 2019, Israeli firm says
Recent comments